|
|
|
|
LEADER |
00000cam a22000004a 4500 |
001 |
7684296 |
003 |
ICU |
005 |
20091019174600.0 |
008 |
081107s2009 nyua b 001 0 eng |
010 |
|
|
|a 2008048873
|
020 |
|
|
|a 9781420087703 (hardcover : alk. paper)
|
020 |
|
|
|a 1420087703 (hardcover : alk. paper)
|
035 |
|
|
|a 2008048873
|
035 |
|
|
|a (OCoLC)271597896
|
040 |
|
|
|a DNLM/DLC
|c DLC
|d YDX
|d BTCTA
|d BAKER
|d YDXCP
|d NLM
|d UtOrBLW
|
042 |
|
|
|a pcc
|
050 |
0 |
0 |
|a HD9665.5
|b .P35 2009
|
060 |
1 |
0 |
|a QV 736
|b P142p 2009
|
082 |
0 |
0 |
|a 615/.10688
|2 22
|
100 |
1 |
|
|a Paich, Mark.
|0 http://id.loc.gov/authorities/names/n2004104655
|1 http://viaf.org/viaf/43697109
|
245 |
1 |
0 |
|a Pharmaceutical product branding strategies :
|b simulating patient flow and portfolio dynamics /
|c Mark Paich, Corey Peck, Jason Valant.
|
250 |
|
|
|a 2nd ed.
|
260 |
|
|
|a New York :
|b Informa Healthcare,
|c c2009.
|
300 |
|
|
|a viii, 295 p. :
|b ill. ;
|c 24 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
500 |
|
|
|a Rev. ed. of: Pharmaceutical product strategy. c2005.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Traditional approaches to brand planning : the disconnect between product strategies and commercial evaluations -- Dynamic modeling approach to brand planning : operationally understanding key marketplace dynamics -- The dynamic modeling language -- Patient flow sector of the standard template dynamic model -- Extensions of the standard template -- Data for the standard template dynamic model -- Specific models of patient flow dynamics -- Dynamic models of doctor adoption of newly released pharmaceuticals -- Agent-based modeling approach -- Treatment attractiveness of pharmaceutical products -- Integrating the three sectors of the standard template dynamic model -- Strategy testing using integrated standard template model -- Dynamic modeling of first-mover advantage and network effects -- Dynamic modeling of new marketplaces : techniques for dealing with uncertainty -- Integrating standard template dynamic models across indications -- Dynamic modeling of pharmaceutical pipeline portfolio issues.
|
650 |
|
0 |
|a Drugs
|x Marketing.
|0 http://id.loc.gov/authorities/subjects/sh2005002422
|
650 |
|
0 |
|a Brand name products
|x Mathematical models.
|
650 |
|
0 |
|a Pharmaceutical industry
|x Mathematical models.
|
650 |
1 |
2 |
|a Drug Industry
|x economics.
|
650 |
1 |
2 |
|a Marketing
|x methods.
|
650 |
2 |
2 |
|a Models, Economic.
|
650 |
|
7 |
|a Brand name products
|x Mathematical models.
|2 fast
|0 http://id.worldcat.org/fast/fst00837895
|
650 |
|
7 |
|a Drugs
|x Marketing.
|2 fast
|0 http://id.worldcat.org/fast/fst00898840
|
650 |
|
7 |
|a Pharmaceutical industry
|x Mathematical models.
|2 fast
|0 http://id.worldcat.org/fast/fst01060161
|
700 |
1 |
|
|a Peck, Corey.
|0 http://id.loc.gov/authorities/names/n2004104656
|1 http://viaf.org/viaf/46159823
|
700 |
1 |
|
|a Valant, Jason.
|0 http://id.loc.gov/authorities/names/n2004104657
|1 http://viaf.org/viaf/48624740
|
700 |
1 |
|
|a Paich, Mark.
|t Pharmaceutical product strategy.
|
903 |
|
|
|a HeVa
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 72ddae4b-9525-56be-817f-f805579fa039
|s 8a19ef8b-c27d-54b7-9e63-1df93b5042e7
|
928 |
|
|
|t Library of Congress classification
|a HD9665.5 .P35 2009
|l JRL
|c JRL-Gen
|i 5417102
|
927 |
|
|
|t Library of Congress classification
|a HD9665.5 .P35 2009
|l JRL
|c JRL-Gen
|e CONE
|b 089005964
|i 8575228
|